Correlation Between Datamatics Global and Biofil Chemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Datamatics Global and Biofil Chemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Datamatics Global and Biofil Chemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Datamatics Global Services and Biofil Chemicals Pharmaceuticals, you can compare the effects of market volatilities on Datamatics Global and Biofil Chemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Datamatics Global with a short position of Biofil Chemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Datamatics Global and Biofil Chemicals.

Diversification Opportunities for Datamatics Global and Biofil Chemicals

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Datamatics and Biofil is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Datamatics Global Services and Biofil Chemicals Pharmaceutica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofil Chemicals Pha and Datamatics Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Datamatics Global Services are associated (or correlated) with Biofil Chemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofil Chemicals Pha has no effect on the direction of Datamatics Global i.e., Datamatics Global and Biofil Chemicals go up and down completely randomly.

Pair Corralation between Datamatics Global and Biofil Chemicals

Assuming the 90 days trading horizon Datamatics Global Services is expected to under-perform the Biofil Chemicals. In addition to that, Datamatics Global is 1.33 times more volatile than Biofil Chemicals Pharmaceuticals. It trades about -0.06 of its total potential returns per unit of risk. Biofil Chemicals Pharmaceuticals is currently generating about -0.04 per unit of volatility. If you would invest  5,647  in Biofil Chemicals Pharmaceuticals on November 7, 2024 and sell it today you would lose (159.00) from holding Biofil Chemicals Pharmaceuticals or give up 2.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Datamatics Global Services  vs.  Biofil Chemicals Pharmaceutica

 Performance 
       Timeline  
Datamatics Global 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Datamatics Global Services are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent forward indicators, Datamatics Global may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Biofil Chemicals Pha 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biofil Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Datamatics Global and Biofil Chemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Datamatics Global and Biofil Chemicals

The main advantage of trading using opposite Datamatics Global and Biofil Chemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Datamatics Global position performs unexpectedly, Biofil Chemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofil Chemicals will offset losses from the drop in Biofil Chemicals' long position.
The idea behind Datamatics Global Services and Biofil Chemicals Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum